$TRAW

Traws Pharma, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · Newtown, PA

TRAW chart

What traders are saying about $TRAW

Latest posts

Traws Pharma, Inc. news

Traws Pharma, Inc. key financials

USD2025202420232022
Revenue$2.8M$226,000$226,000$226,000
Net income$9.2M-$166.5M-$18.9M-$19.0M
Diluted EPS$0.82$-35.21$-22.57$-0.91
Total assets (year end)$10.6M$25.0M$22.7M$39.4M
Cash and equivalents (year end)––$20.6M$38.5M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Traws Pharma, Inc.

Ticker
TRAW (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Newtown, PA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1130598
Former names
Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC

Frequently asked questions

What exchange is Traws Pharma, Inc. listed on?

Traws Pharma, Inc. trades on the Nasdaq under the ticker symbol TRAW.

What industry is Traws Pharma, Inc. in?

Traws Pharma, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Traws Pharma, Inc. headquartered?

Traws Pharma, Inc.'s business address on file with the SEC is in Newtown, PA.

When does Traws Pharma, Inc.'s fiscal year end?

Traws Pharma, Inc.'s fiscal year ends on December 31.

How much revenue did Traws Pharma, Inc. report?

Traws Pharma, Inc. reported $2.8M in revenue for calendar year 2025, according to its SEC filings.